Clinical Trial Update: Saw Palmetto Extract in Benign Prostatic Hyperplasia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Saw Palmetto Extract for Benign Prostatic Hyperplasia has completed, sponsored by the National Institute of Diabetes and Dig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Saw Palmetto Extract

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED